Evotec SE

Evotec SEverified

EVO

Price:

$4.4

Market Cap:

$1.43B

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company wa...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2004-02-05

Stock Exchange

NASDAQ

Ticker

EVO

The Current Ratio as of November 2024 (TTM) for Evotec SE (EVO) is 1.83

According to Evotec SE’s latest financial reports and current stock price. The company's current Current Ratio is 1.83. This represents a change of -6.04% compared to the average of 1.95 of the last 4 quarters.

Evotec SE (EVO) Historical Current Ratio (quarterly & annually)

How has EVO Current Ratio performed in the past?

The mean historical Current Ratio of Evotec SE over the last ten years is 2.54. The current 1.83 Current Ratio has changed 7.13% with respect to the historical average. Over the past ten years (40 quarters), EVO's Current Ratio was at its highest in in the March 2017 quarter at 5.21. The Current Ratio was at its lowest in in the April 2023 quarter at 0.

Quarterly (TTM)
Annual

Average

2.54

Median

2.79

Minimum

0.73

Maximum

3.79

Evotec SE (EVO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Evotec SE Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 106.18%

Maximum Annual Current Ratio = 3.79

Minimum Annual Increase = -68.20%

Minimum Annual Current Ratio = 0.73

Quarterly (TTM)
Annual
YearCurrent RatioChange
20231.94-38.85%
20223.18-6.29%
20213.397.34%
20203.1620.46%
20192.62106.18%
20181.2773.51%
20170.73-68.20%
20162.31-22.09%
20152.96-21.88%
20143.7920.46%

Evotec SE (EVO) Average Current Ratio

How has EVO Current Ratio performed in the past?

The current Current Ratio of Evotec SE (EVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.84

5-year avg

2.86

10-year avg

2.54

Evotec SE (EVO) Current Ratio vs. Peers

How is EVO’s Current Ratio compared to its peers?

Evotec SE’s Current Ratio is less than Prestige Consumer Healthcare Inc. (3.23), less than Supernus Pharmaceuticals, Inc. (1.91), greater than Collegium Pharmaceutical, Inc. (1.11), less than Deciphera Pharmaceuticals, Inc. (4.19), greater than Eagle Pharmaceuticals, Inc. (1.70), less than ANI Pharmaceuticals, Inc. (3.97), less than Phibro Animal Health Corporation (2.94), less than Pacira BioSciences, Inc. (6.82), less than Dr. Reddy's Laboratories Limited (2.55), less than Silver Spike Investment Corp. (6.09), less than Regencell Bioscience Holdings Limited (41.92), less than Neurocrine Biosciences, Inc. (4.37),

Build a custom stock screener for Evotec SE (EVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evotec SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evotec SE (EVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evotec SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Evotec SE's Current Ratio?

How is the Current Ratio calculated for Evotec SE (EVO)?

What is the highest Current Ratio for Evotec SE (EVO)?

What is the 3-year average Current Ratio for Evotec SE (EVO)?

What is the 5-year average Current Ratio for Evotec SE (EVO)?

How does the current Current Ratio for Evotec SE (EVO) compare to its historical average?